- Home
- EYE vs MLTX Comparison
EYE vs MLTX Comparison
Compare EYE & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EYE | MLTX |
|---|---|---|
| Founded | 1990 | 2021 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | 2017 | 2020 |
Fundamental Metrics
Financial Performance| Metric | EYE | MLTX |
|---|---|---|
| Price | $20.72 | $19.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 12 |
| Target Price | ★ $31.22 | $27.50 |
| AVG Volume (30 Days) | ★ 2.1M | 1.5M |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 202.78 | N/A |
| EPS | ★ 0.38 | N/A |
| Revenue | ★ $1,987,488,000.00 | N/A |
| Revenue This Year | $5.56 | N/A |
| Revenue Next Year | $6.58 | N/A |
| P/E Ratio | $54.32 | ★ N/A |
| Revenue Growth | ★ 9.00 | N/A |
| 52 Week Low | $14.75 | $5.95 |
| 52 Week High | $30.02 | $62.75 |
Technical Indicators
Market Signals| Indicator | EYE | MLTX |
|---|---|---|
| Relative Strength Index (RSI) | 64.59 | 52.93 |
| Support Level | $14.84 | $15.89 |
| Resistance Level | $29.55 | $21.14 |
| Average True Range (ATR) | 0.89 | 0.91 |
| MACD | 0.21 | -0.07 |
| Stochastic Oscillator | 73.60 | 46.10 |
Price Performance
Historical ComparisonAbout EYE National Vision Holdings Inc.
National Vision Holdings Inc. is an optical retailer in the United States. Its product portfolio includes eyeglasses, sunglasses, contact lenses, accessories, and other related products. The company operates through a single operating segment. The Owned and Host segment includes the company-owned brands America's Best and Eyeglass World. In America's Best stores, vision care services are provided by optometrists or by independent professional corporations. The Host segment consists of Military and Fred Meyer locations, where eye exams are provided by independent optometrists.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.